For instance, Rody et al. showed a favorable prognostic effect of a T-cell metagene in estrogen receptor (ER)-negative as well as in human epidermal growth factor receptor 2 (HER2)-positive breast cancer [8]. The gene discussed is ERBB2; the disease is breast carcinoma.